{
    "paper_id": "a6d64a5408d293ad9db6f1516591722ee9527e77",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "control should be mandatory.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose"
        },
        {
            "text": "Correspondence: There are at least two reasons why hyperglycemia, particularly an acute one, can be very dangerous during the SARS-CoV-2 infection. One is that an acute increase of glycemia is accompanied by a huge increase of inflammatory mediators (3).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Antonio Ceriello"
        },
        {
            "text": "Clearly, knowing the role of the \"cytokines storm\" in the COVID-19 this is an effect that must be avoided. Another reason seems to be very specific for COVID-19 and it is related to the binding of SARS-CoV-2 to ACE2 (4). The glycosylation, a reaction that can be induced by hyperglycemia, of the ACE2 is needed for the linkage of the virus to this cellular receptor (4) . Therefore, high and aberrantly glycosylated ACE2",
            "cite_spans": [
                {
                    "start": 366,
                    "end": 369,
                    "text": "(4)",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Antonio Ceriello"
        },
        {
            "text": "in the tissue in uncontrolled hyperglycemia could favor the cellular intrusion of SARS-CoV2, thus leading to a higher propensity to COVID-19 infection and a higher disease severity (4) . It is also likely that it is the amount of glycosylated ACE2 receptor, and not simply the amount of ACE2 alone, that is responsible for virus binding and fusion (4) . It is well know, however that the hyperglycemia-related process of glycosylation is at the beginning a reversible process, going through the so called \"labile glycosylation\", which is reversible also in vivo (5).",
            "cite_spans": [
                {
                    "start": 181,
                    "end": 184,
                    "text": "(4)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 348,
                    "end": 351,
                    "text": "(4)",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Antonio Ceriello"
        },
        {
            "text": "Therefore, it is conceivable that a fast normalization of hyperglycemia during COVID-19 may results in a decrease of inflammatory cytokines release and in a lower Tel. +393425054447. Email: antonio.ceriello@hotmail.it",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Antonio Ceriello"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bode",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Garrett",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Messler",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mcfarland",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Crowe",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Booth",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Diabetes Sci Technol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Admission hyperglycemia and radiological findings of SARS-COv2 in patients with and without diabetes",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Iacobellis",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Penaherrera",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Bermudez",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "B"
                    ],
                    "last": "Mizrachi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Diab Res Clin Pract",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ceriello",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "W"
                    ],
                    "last": "Zarich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Testa",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Am Coll Cardiol",
            "volume": "53",
            "issn": "5",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Hyperglycemia, hydroxychloroquine, and the COVID-19 epidemic",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Brufsky",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25887"
                ]
            }
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Influence of labile glucose adducts on glycosylated protein assay by aminophenylboronic acid affinity chromatography: in vivo studies",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ceriello",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Paolisso",
                    "suffix": ""
                },
                {
                    "first": "Dello",
                    "middle": [],
                    "last": "Russo",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Giugliano",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sgambato",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1985,
            "venue": "Acta Diabetol Lat",
            "volume": "22",
            "issn": "",
            "pages": "81--82",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "The author does not have conflicts of interest to declare",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "+393425054447. Email: antonio.ceriello@hotmail.it Key words: Cardiovascular complications; COVID-19, HyperglycemiaEvidence in the COVID-19 pandemic shows that hyperglycemia, not only in people with diabetes, worsens the prognosis and increases the risk to die (1-2). It is, moreover, emerging that particularly the hyperglycemia at the admission in the hospital is a very bad prognostic factor (1-2), suggesting that hyperglycemia in the very early phase of the disease may play a particular role in determining the seriousness of the prognosis.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "ACE2 binding capacity for the virus, two facts which consistently might help in improving the prognosis in people affected by SARS-",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Journal Pre-proofs Editorial Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory Please cite this article as: A. Ceriello, Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory, Diabetes Research and Clinical Practice (2020), doi: https://doi.org/ 10.1016/j.diabres.2020.108186",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}